[1] BOLTON-MAGGS P H,COHEN H.Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety[J].Br J Haematol,2013,163(3):303-314.
[2] EDER A F,DY B A,DEMERSE B,et al.Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions[J].Transfusion,2017,57(12):2969-2976.
[3] DE KORTE D,MARCELIS J.Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections[J].Int J Clin Transfus Med,2014:29.
[4] PASTER B J,OLSEN I,AAS J A,et al.The breadth of bacterial diversity in the human periodontal pocket and other oral sites[J].Periodontol 2000,2006,42: 80-87.
[5] KHAIRAT O.The non-aerobes of post-extraction bacteremia[J].J Dent Res,1966,45(4):1191-1197.
[6] RAJASUO A,PERKKI K,NYFORS S,et al.Bacteremia following surgical dental extraction with an emphasis on anaerobic strains[J].J Dent Res,2004,83(2):170-174.
[7] COBE H M.Transitory bacteremia[J].Oral Surg Oral Med Oral Pathol,1954,7(6):609-615.
[8] GOLDMAN M,BLAJCHMAN M A.Blood product-associated bacterial Sepsis[J].Transfus Med Rev,1991,5(1): 73-83.
[9] 卫生部, 国家标准化管理委员会. 献血者健康检查要求[S]. 2012.
[10] European Directorate for the Quality of Medicines ＆ HealthCare (EDQM) Council of Europe. Guide to the preparation, use and quality assurance of blood components(Recommendation No. R(95)15)[M].19th ed. Strasbourg: EDQM, 2017-04-04.
[11] NESS P M,PERKINS H A.Transient bacteremia after dental procedures and other minor manipulations[J].Transfusion,1980,20(1):82-85.
[12] OLSEN I.Update on bacteraemia related to dental procedures[J].Transfus Apher Sci,2008,39(2): 173-178.
[13] KLAUSEN S S,HERVIG T,SEGHATCHIAN J,et al.Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients[J].Transfus Apher Sci,2014,51(2):97-102.
[14] MARK,K.FUNG.AABB技术手册[M].18版.长沙:中南大学出版社,2019.
[15] SHELLEY E D.Skin microbiology: relevance to clinical infection[J].JAMA: J Am Med Assoc,1982,247(17): 2423.
[16] GOLDMAN M, LEE JH, BLAJCHMAN MA.Skin antisepsis and initial aliquot diversion. In: Brecher MA, editor. Bacterial and Parasitic Contamina-tion of Blood Components[M]. Bethesda (MD):AABB, 2003:31-56.
[17] MCDONALD C P,LOWE P,ROY A,et al.Evaluation of donor arm disinfection techniques[J].Vox Sang,2001,80(3):135-141.
[18] MCDONALD C,MCGUANE S,THOMAS J,et al.A novel rapid and effective donor arm disinfection method[J].Transfusion,2010,50(1):53-58.
[19] RAMIREZ-ARCOS S,GOLDMAN M.Skin disinfection methods: prospective evaluation and postimplementation results[J].Transfusion,2010,50(1):59-64.
[20] BENJAMIN R J,DY B,WARREN R,et al.Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets[J].Transfusion,2011,51(3):531-538.
[21] GIBSON T,NORRIS W.Skin fragments removed by injection needles[J].Lancet,1958,272(7054): 983-985.
[22] DE KORTE D,MARCELIS J H,VERHOEVEN A J,et al.Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections[J].Vox Sang,2002,83(1):13-16.
[23] DE KORTE D,CURVERS J,DE KORT W L,et al.Effects of skin disinfection method,deviation bag,and bacterial screening on clinical safety of platelet transfusions in the Netherlands[J].Transfusion,2006,46(3):476-485.
[24] EDER A F,KENNEDY J M,DY B A,et al.Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety[J].Transfusion,2009,49(8):1554-1563.
[25] NIGHTINGALE M J,BEARD M J,BENNETT J,et al.The donor line break Cannula: effect on the donation process,blood component quality and transfusion microbiology testing of an important new blood bag safety feature[J].Transfusion Med,2013,23(4):219-225.
[26] MCDONALD C P.Interventions implemented to reduce the risk of transmission of bacteria by transfusion in the English national blood service[J].Transfus Med Hemother,2011,38(4):255-258.
[27] STÖRMER M,VOLLMER T.Diagnostic methods for platelet bacteria screening: current status and developments[J].Transfus Med Hemother,2014,41(1): 5.
[28] WHITE S K,SCHMIDT R L,WALKER B S,et al.Bacterial contamination rate of platelet components by primary culture: a systematic review and meta-analysis[J].Transfusion,2020,60(5):986-996.
[29] PEARCE S,ROWE G P,FIELD S P.Screening of platelets for bacterial contamination at the Welsh Blood Service[J].Transfus Med,2011,21(1):25-32.
[30] STÖRMER M,ARROYO A,BRACHERT J,et al.Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID),subgroup on bacteria[J].Vox Sang,2012,102(1):22-31.
[31] LEVY J H,NEAL M D,HERMAN J H.Bacterial contamination of platelets for transfusion: strategies for prevention[J].Crit Care,2018,22(1):271.
[32] MUNDT J M,ROUSE L,VAN DEN BOSSCHE J,et al.Chemical and biological mechanisms of pathogen reduction technologies[J].Photochem Photobiol,2014,90(5):957-964.
[33] PROWSE C V.Component pathogen inactivation: a critical review[J].Vox Sang,2013,104(3): 183-199.
[34] SCHLENKE P.Pathogen inactivation technologies for cellular blood components: an update[J].Transfus Med Hemother,2014,41(4):309-325.
[35] 徐蓓,杨剑豪,邱颖婕,等.2016—2018年上海地区单采血小板制品细菌污染检测结果分析与展望[J].中国输血杂志,2018,31(9):989-993.
[36] RAMIREZ-ARCOS S,DIFRANCO C,MCINTYRE T,et al.Residual risk of bacterial contamination of platelets: six years of experience with sterility testing[J].Transfusion,2017,57(9):2174-2181.
[37] MCDONALD C,ALLEN J,BRAILSFORD S,et al.Bacterial screening of platelet components by National Health Service Blood and Transplant,an effective risk reduction measure[J].Transfusion,2017,57(5):1122-1131.
[38] HUME H A,DDUNGU H,ANGOM R,et al.Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination,recipient characteristics,and acute transfusion reactions[J].Transfusion,2016,56(8): 1951-1959.
[39] COREAN J,AL-TIGAR R,PYSHER T,et al.Quality improvement after multiple fatal transfusion-transmitted bacterial infections[J].Am J Clin Pathol,2018,149(4):293-299.
[40] GKOUMASSI E,KLEIN-BOSGOED C,DIJKSTRA-TIEKSTRA M J,et al.Noninvasive pH monitoring of platelet concentrates: a large field test[J].Transfusion,2013,53(10):2287-2292.
[41] LEE C K,WONG H K,HO P L,et al.Significant bacterial contamination risk reduction with the use of diversion pouch[J].Transfusion Med,2012,22(6):404-408.
[42] VOLLMER T,DREIER J,SCHOTTSTEDT V,et al.Detection of bacterial contamination in platelet concentrates by a sensitive flow cytometric assay (BactiFlow): a multicentre validation study[J].Transfusion Med,2012,22(4):262-271.
[43] HEATON W A,GOOD C E,GALLOWAY-HASKINS R,et al.Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units[J].Transfusion,2014,54(6):1634-1641.
[44] JACOBS MR, BAJAKSOUZIAN S, YOMTOVIAN R, et al.Detection of bacteria in Leukocyte-reduced whole blood derived platelet units using the Immunetics BacTx Test: SP368[J]. Transfusion,2010,50:194A.
[45] SIREIS W,RÜSTER B,DAISS C,et al.Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany[J].Vox Sang,2011,101(3):191-199.
[46] CHETOUANE Y,DUBOURG G,GALLIAN P,et al.Rapid identification of microorganisms from platelet concentrates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry after short-term incubation on liquid medium[J].Transfusion,2018,58(3):766-773.
[47] FDA. In: CBER, editor. Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Draft Guidance for Industry[M]. Silver Spring: US Food and Drug Administration;2019.
[48] KACKER S,BLOCH E M,NESS P M,et al.Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions[J].Transfusion,2019,59(4):1291-1299. |
